Search research articles
Contact Us
Filters
Showing results (381-390 of 566) with videos related to
Page
of 57
Sort By:
Urology
|
April 5, 2016
Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical Practice
Adam M Luchey, Neil J Manimala, Shohreh Dickinson, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 9, 2020
Focal bipolar radiofrequency ablation for localized prostate cancer: Safety and feasibility
Ahmet Murat Aydin, Kenneth Gage, Jasreman Dhillon, et al.
Current Oncology (Toronto, Ont.)
|
May 15, 2023
The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on Brassetti et al. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The <i>Tetrafecta</i> Achievement. <i>Curr. Oncol.</i> 2023, <i>30</i>, 1882-1892
Matthias May, Steffen Lebentrau, Ben Ayres, et al.
The Journal of Urology
|
June 17, 2025
Predictors and Patterns of Nonurothelial Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma (UCAN Collaboration)
Andrew B Katims, Amy L Tin, Melissa Assel, et al.
JCO Global Oncology
|
November 12, 2021
Dramatic Impact of Centralization and a Multidisciplinary Bladder Cancer Program in Reducing Mortality: The CABEM Project
Fernando Korkes, Frederico Timóteo, Suelen Martins, et al.
The Oncologist
|
March 14, 2023
Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy
Sean M Hacking, Dean Pavlick, Yihong Wang, et al.
European Urology Oncology
|
November 18, 2023
Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?
Amanda A Myers, Alberto Briganti, Bradley Leibovich, et al.
Clinical Genitourinary Cancer
|
January 3, 2022
Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients' Voice or a Missed Opportunity
Juskaran Chadha, Jacob J Adashek, Heather Jim, et al.
Aktuelle Urologie
|
June 20, 2023
[Initial presentation of the Pentafecta score as a quality instrument for outcome evaluation of primary surgical treatment in patients with penile cancer]
Matthias May, Steffen Lebentrau, Nick Watkin, et al.
The Journal of Urology
|
October 3, 2023
Total Margin Control Is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma
Katie A O'Connell, Jacob L Thomas, Fadi Murad, et al.
Page
of 57
Search research articles
Search
Showing results (381-390 of 566) with videos related to
Sort By:
Page
of 57
Urology
|
April 5, 2016
Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical Practice
Adam M Luchey, Neil J Manimala, Shohreh Dickinson, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 9, 2020
Focal bipolar radiofrequency ablation for localized prostate cancer: Safety and feasibility
Ahmet Murat Aydin, Kenneth Gage, Jasreman Dhillon, et al.
Current Oncology (Toronto, Ont.)
|
May 15, 2023
The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on Brassetti et al. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The <i>Tetrafecta</i> Achievement. <i>Curr. Oncol.</i> 2023, <i>30</i>, 1882-1892
Matthias May, Steffen Lebentrau, Ben Ayres, et al.
The Journal of Urology
|
June 17, 2025
Predictors and Patterns of Nonurothelial Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma (UCAN Collaboration)
Andrew B Katims, Amy L Tin, Melissa Assel, et al.
JCO Global Oncology
|
November 12, 2021
Dramatic Impact of Centralization and a Multidisciplinary Bladder Cancer Program in Reducing Mortality: The CABEM Project
Fernando Korkes, Frederico Timóteo, Suelen Martins, et al.
The Oncologist
|
March 14, 2023
Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy
Sean M Hacking, Dean Pavlick, Yihong Wang, et al.
European Urology Oncology
|
November 18, 2023
Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?
Amanda A Myers, Alberto Briganti, Bradley Leibovich, et al.
Clinical Genitourinary Cancer
|
January 3, 2022
Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients' Voice or a Missed Opportunity
Juskaran Chadha, Jacob J Adashek, Heather Jim, et al.
Aktuelle Urologie
|
June 20, 2023
[Initial presentation of the Pentafecta score as a quality instrument for outcome evaluation of primary surgical treatment in patients with penile cancer]
Matthias May, Steffen Lebentrau, Nick Watkin, et al.
The Journal of Urology
|
October 3, 2023
Total Margin Control Is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma
Katie A O'Connell, Jacob L Thomas, Fadi Murad, et al.
Page
of 57